Concord Biotech announced that the United States Food and Drug
Administration (USFDA) had conducted an inspection at Company's Manufacturing Unit III, Plot No. 84 And 668, Ranasar and Malawada, Limbasi Sojitra Road, Near Limbasi, Taluka- Matar, Kheda, Gujarat
from 26 June 2023 to 30 June 2023.
Pursuant to the above inspection by United States Food and Drug Administration (USFDA), the Company has now received the Establishment Inspection Report (EIR) indicating closure of inspection
and classifying the facility as "no action indicated" (NAI).
Based on this inspection and the USFDA NAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP).
|